The United Kingdom became the first country to
grant emergency approval (NYT) for a coronavirus vaccine developed by the University of Oxford and AstraZeneca as the world confronts the spread of a more contagious variant of the virus.
Though not as effective as the vaccines developed by Pfizer-BioNTech and Moderna, the Oxford-AstraZeneca vaccine is much cheaper and easier to store, which will make it an attractive option for poorer countries and remote regions. Additionally, the Chinese company Sinopharm
released data today (WaPo) showing that one of its vaccines is nearly 80 percent effective. Sinopharm vaccines have not received regulatory approval, but they have already been given to hundreds of thousands of Chinese people on an emergency basis. Meanwhile, countries around the world are reporting cases of a coronavirus variant that is more contagious, though it is not believed to be more deadly or vaccine resistant. The United States
reported its first case (NYT) of the variant in the state of Colorado yesterday.